Loading...
Loading...
Browse all stories on DeepNewz
VisitNyxoah Launches App-Controlled Genio Device in UK for Sleep Apnoea Relief, Fitting First Patients
Dec 13, 2024, 09:57 AM
Nyxoah has announced the commercial launch of its innovative therapy, Genio, in the United Kingdom. This new app-controlled nerve stimulator aims to provide relief for millions suffering from sleep apnoea. The device works by stimulating the nerves in the tongue, helping patients breathe more easily during the night. The first patients in the UK have already been fitted with this microchip, marking a significant advancement in the treatment options available for sleep apnoea. This development is expected to bring relief not only to patients but also to their partners, who often endure the effects of snoring associated with the condition.
View original story
Markets
No • 50%
Yes • 50%
Market analysis reports from reputable sources
No • 50%
Yes • 50%
FDA announcements or press releases from Nyxoah
Yes • 50%
No • 50%
Official announcements from the NHS or Nyxoah
Less than 50 hospitals • 25%
More than 200 hospitals • 25%
101 to 200 hospitals • 25%
50 to 100 hospitals • 25%
Reports from UK healthcare institutions or Nyxoah
More than 15 countries • 25%
1 to 5 countries • 25%
6 to 10 countries • 25%
11 to 15 countries • 25%
Press releases from Nyxoah or international market reports
71% to 90% • 25%
More than 90% • 25%
Less than 50% • 25%
50% to 70% • 25%
Clinical trial results or patient surveys published by Nyxoah